- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 419/14 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Patent holdings for IPC class C07D 419/14
Total number of patents in this class: 155
10-year publication summary
|
5
|
9
|
10
|
10
|
17
|
16
|
5
|
18
|
12
|
12
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Astex Therapeutics Limited | 237 |
7 |
| Merck Patent GmbH | 5861 |
6 |
| Bayer Cropscience AG | 2055 |
6 |
| Amgen Inc. | 4071 |
5 |
| Rigel Pharmaceuticals, Inc. | 539 |
5 |
| BASF SE | 20874 |
4 |
| Celgene Corporation | 1412 |
4 |
| Novartis AG | 10882 |
3 |
| AstraZeneca AB | 2924 |
3 |
| Janssen Pharmaceutica N.V. | 3407 |
3 |
| Bayer AG | 3319 |
3 |
| Glaxosmithkline Intellectual Property Development Limited | 757 |
3 |
| Daiichi Sankyo Company, Limited | 1859 |
3 |
| Dana-Farber Cancer Institute, Inc. | 2558 |
3 |
| Duk San Neolux Co., Ltd. | 642 |
3 |
| Kyoto Pharmaceutical Industries, Ltd. | 19 |
3 |
| Jacobio Pharmaceuticals Co., Ltd. | 98 |
3 |
| LG Chem, Ltd. | 17581 |
2 |
| AstraZeneca UK Limited | 655 |
2 |
| Bayer Healthcare AG | 98 |
2 |
| Other owners | 82 |